Correlation Between Design Therapeutics and Adial Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Adial Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Adial Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Adial Pharmaceuticals, you can compare the effects of market volatilities on Design Therapeutics and Adial Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Adial Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Adial Pharmaceuticals.
Diversification Opportunities for Design Therapeutics and Adial Pharmaceuticals
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Design and Adial is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Adial Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adial Pharmaceuticals and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Adial Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adial Pharmaceuticals has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Adial Pharmaceuticals go up and down completely randomly.
Pair Corralation between Design Therapeutics and Adial Pharmaceuticals
Given the investment horizon of 90 days Design Therapeutics is expected to generate 0.37 times more return on investment than Adial Pharmaceuticals. However, Design Therapeutics is 2.69 times less risky than Adial Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Adial Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest 285.00 in Design Therapeutics on March 7, 2024 and sell it today you would earn a total of 121.00 from holding Design Therapeutics or generate 42.46% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 98.41% |
Values | Daily Returns |
Design Therapeutics vs. Adial Pharmaceuticals
Performance |
Timeline |
Design Therapeutics |
Adial Pharmaceuticals |
Design Therapeutics and Adial Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Design Therapeutics and Adial Pharmaceuticals
The main advantage of trading using opposite Design Therapeutics and Adial Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Adial Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adial Pharmaceuticals will offset losses from the drop in Adial Pharmaceuticals' long position.Design Therapeutics vs. Artelo Biosciences | Design Therapeutics vs. Nutriband | Design Therapeutics vs. SAB Biotherapeutics |
Adial Pharmaceuticals vs. Artelo Biosciences | Adial Pharmaceuticals vs. Nutriband | Adial Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |